Entecavir

Basic Information


CAS ID: 142217-69-4
Molecular Formula: C12H15N5O3
Molecular Weight: 277.3 g/mol
Monoisotopic Mass: 277.1175 g/mol
Class: Small Molecule
Natural Product: No
Other Names: BARACLUDE | ENTECAVIR | SQ34676 | BMS-200475-01
Analysis: Drug repositioning mechanism analysis

NH2 N N N HO OH O NH


Compound Structure and Identifier


InChI: InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1 See All
InChI Key: QDGZDCVAUDNJFG-FXQIFTODSA-N
Smiles: NC1=Nc2c(ncn2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1 See All
Molfile: Download


Related Target



Related Fibrosis Property


Trial Record 1

ClinicalTrial ID NCT01938781 Disease Liver fibrosis
Phase Phase 4 Status Completed
First Received September 10, 2013 Last Verified July 27, 2018
Sponsor Beijing Friendship Hospital

Trial Record 2

ClinicalTrial ID NCT01341106 Disease Liver fibrosis
Phase Phase 4 Status Terminated
First Received April 25, 2011 Last Verified September 23, 2015
Sponsor RWTH Aachen University

Trial Record 3

ClinicalTrial ID NCT01217632 Disease Liver fibrosis
Phase Phase 2 Status Terminated
First Received October 8, 2010 Last Verified August 16, 2016
Sponsor FibroGen

Trial Record 4

ClinicalTrial ID NCT02849132 Disease Liver fibrosis
Phase Phase 4 Status Recruiting
First Received July 29, 2016 Last Verified July 27, 2018
Sponsor Beijing Friendship Hospital

Trial Record 5

ClinicalTrial ID NCT02241616 Disease Liver fibrosis
Phase Phase 4 Status Recruiting
First Received September 16, 2014 Last Verified October 15, 2018
Sponsor ShuGuang Hospital

Trial Record 6

ClinicalTrial ID NCT01943617 Disease Liver fibrosis
Phase Phase 4 Status Completed
First Received September 17, 2013 Last Verified July 27, 2018
Sponsor Beijing Friendship Hospital

Trial Record 7

ClinicalTrial ID NCT01938820 Disease Liver fibrosis
Phase Phase 4 Status Completed
First Received September 10, 2013 Last Verified July 27, 2018
Sponsor Beijing Friendship Hospital

Trial Record 8

ClinicalTrial ID NCT01799486 Disease Liver fibrosis
Phase Phase 4 Status Unknown
First Received February 26, 2013 Last Verified February 26, 2013
Sponsor Lin Bingliang

Trial Record 9

ClinicalTrial ID NCT01718587 Disease Liver fibrosis
Phase Phase 1,Phase 2 Status Unknown
First Received October 31, 2012 Last Verified October 31, 2012
Sponsor General Hospital of Chinese Armed Police Forces

Trial Record 10

ClinicalTrial ID NCT01693679 Disease Liver fibrosis
Phase Phase 4 Status Unknown
First Received September 26, 2012 Last Verified September 26, 2012
Sponsor Shao-quan Zhang

Trial Record 11

ClinicalTrial ID NCT01686698 Disease Liver fibrosis
Phase Phase 4 Status Completed
First Received September 18, 2012 Last Verified May 19, 2016
Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Trial Record 12

ClinicalTrial ID NCT01720238 Disease Liver fibrosis
Phase Status Unknown
First Received November 2, 2012 Last Verified July 28, 2015
Sponsor Beijing Friendship Hospital

Trial Record 13

ClinicalTrial ID NCT02238860 Disease Liver fibrosis
Phase Phase 4 Status Unknown
First Received September 12, 2014 Last Verified September 12, 2014
Sponsor Asian Institute Of Medical Sciences

Trial Record 14

ClinicalTrial ID NCT00663182 Disease Liver fibrosis
Phase Phase 4 Status Unknown
First Received April 22, 2008 Last Verified April 23, 2008
Sponsor Shanghai Changzheng Hospital

Trial Record 15

ClinicalTrial ID NCT02241590 Disease Liver fibrosis
Phase Phase 4 Status Recruiting
First Received September 16, 2014 Last Verified October 15, 2018
Sponsor ShuGuang Hospital

Trial Record 16

ClinicalTrial ID NCT00823550 Disease Liver fibrosis
Phase Phase 4 Status Unknown
First Received January 15, 2009 Last Verified December 16, 2010
Sponsor Yonsei University

Trial Record 17

ClinicalTrial ID NCT03345498 Disease Liver fibrosis
Phase Status Recruiting
First Received November 17, 2017 Last Verified November 20, 2017
Sponsor Sanjay Gandhi Postgraduate Institute of Medical Sciences

Related Link


PubChem: 153941
ChEMBL: CHEMBL713